Portland Press Limited today announced an across-the-board increase in Impact Factors for its molecular bioscience publications.
The 2013 InCites Journal Citation Reports (Thomson Reuters, 2014) show that Clinical Science, Biochemical Journal, Essays in Biochemistry, Biochemical Society Transactions and Bioscience Reports all received increases in their Impact Factors. The journals are owned by the Biochemical Society and published by Portland Press Limited.
2014 Impact Factors (2013 Impact Factor in brackets):
Clinical Science 5.629 (4.859)
Biochemical Journal 4.779 (4.654)
Essays in Biochemistry 4.390 (3.468)
Biochemical Society Transactions 3.238 (2.587)
Bioscience Reports (open access) 2.853 (1.876)
"While they should be treated with care, Impact Factors provide a useful measurement of the level of interest in the research published in academic journals," says Head of Publishing Niamh O'Connor.
"I am delighted that the entire family of Portland Press Limited's journals have seen an increase in their Impact Factors. This is a testament to the hardworking people behind our publications and the authors that chose to publish in our journals."
Dr O'Connor said of each publication:
"Clinical Science has now cemented its place in the top 10 journals publishing primary research in its Medicine (Research & Experimental) category.
"The Biochemical Journal has a proud history as the Society's oldest publication and its latest Impact Factor reinforces the strong value it provides to the biochemistry sector.
"Bioscience Reports continues to go from strength-to-strength in its new life as an entirely open access publication, which it became in 2012. The latest increase reinforces Bioscience Reports as a worthy open access option for authors.
"Biochemical Society Transactions, which publishes the proceedings of Biochemical Society conferences, has moved into the top half of publications within the Biochemistry and Molecular Biology category. The Impact Factor increase should be celebrated twice, not just in respect to the high-quality of the journal, but as a reflection of the excellent programme of conferences and events the Biochemical Society puts on every year."
"Essays in Biochemistry's Impact Factor increase demonstrates its continuing value as a biochemistry publication for undergraduates and first year postgraduates."
Dr O'Connor said: "An across-the-board increase in Impact Factors is an exciting development in a very exciting period for Portland Press Limited, which continues with our move to the HighWire Open Platform next year. With this move, our authors and readers will benefit from the ease in which one can find, read, share and explore our authoritative catalogue of papers."
Biochemical Society Chair Steve Busby said the impact factor increases was great news for the Society.
"Income generated from the sale of Portland Press Limited's journals goes towards the Society's conferences, grants and policy and education initiatives. This latest acknowledgement of the strength and interest in our journals will flow through to the Society and the entire bioscience community."